What is Arzerra (ofatumumab), and how does it work?
Generic drug: ofatumumab
Brand name: Arzerra
Arzerra (ofatumumab) Injection is a monoclonal antibody used to treat chronic lymphocytic leukemia. Arzerra is usually given after other medications have been tried without successful treatment of symptoms.
What are the side effects of Arzerra?
Common side effects of Arzerra include:
- swelling of hands/ankles/feet,
- trouble sleeping,
- skin rash, or
- cold symptoms such as stuffy nose, sneezing, and sore throat.
Arzerra decreases bone marrow function, an effect that may lead to a low number of blood cells such as red cells, white cells, and platelets. This side effect of Arzerra can cause anemia, decrease your body's ability to fight an infection, or cause easy bruising or bleeding. Tell your doctor if you have the following symptoms:
- easy bruising/bleeding,
- pale skin,
- unusual tiredness, or
- signs of infection (such as fever, chills, cough, persistent sore throat).
- Hepatitis B Virus (HBV) reactivation can occur in patients receiving CD20-directed cytolytic antibodies, including Arzerra, in some cases resulting in fulminant hepatitis, hepatic failure, and death.
- Progressive Multifocal Leukoencephalopathy (PML) resulting in death can occur in patients receiving CD20-directed cytolytic antibodies, including Arzerra.
What is the dosage for Arzerra?
Recommended Dosage Regimen
- Dilute and administer as an intravenous infusion according to the following schedules.
- Do not administer as an intravenous push or bolus or as a subcutaneous injection.
- Pre-medicate before each infusion.
Previously Untreated CLL:
The recommended dosage and schedule in combination with chlorambucil is:
- 300 mg on Day 1, followed 1 week later by 1,000 mg on Day 8 (Cycle 1), followed by
- 1,000 mg on Day 1 of subsequent 28-day cycles for a minimum of 3 cycles until best response or a maximum of 12 cycles.
The recommended dosage and schedule in combination with fludarabine and cyclophosphamide is:
- 300 mg on Day 1, followed 1 week later by 1,000 mg on Day 8 (Cycle 1), followed by
- 1,000 mg on Day 1 of subsequent 28-day cycles for a maximum of 6 cycles.
Extended Treatment In CLL:
The recommended dosage and schedule as single-agent extended treatment in CLL is:
- 300 mg on Day 1, followed by
- 1,000 mg 1 week later on Day 8, followed by
- 1,000 mg 7 weeks later and every 8 weeks thereafter for up to a maximum of 2 years.
The recommended dosage and schedule is 12 doses administered as follows:
- 300 mg initial dose on Day 1, followed 1 week later by
- 2,000 mg weekly for 7 doses (Infusions 2 through 8), followed 4 weeks later by
- 2,000 mg every 4 weeks for 4 doses (Infusions 9 through 12).
Administer Arzerra in an environment where facilities to adequately monitor and treat infusion reactions are available.
Prepare all doses in 1,000 mL of 0.9% Sodium Chloride Injection, USP.
Previously Untreated CLL, Relapsed CLL, And Extended Treatment In CLL:
- For initial 300-mg dose: Initiate infusion at a rate of 3.6 mg/hour (12 mL/hour).
- For subsequent infusions of 1,000 mg: Initiate infusion at a rate of 25 mg/hour (25 mL/hour). Initiate infusion at a rate of 12 mg/hour if a Grade 3 or greater infusion-related adverse event was experienced during the previous infusion.
In the absence of an infusion-related adverse event, the rate of infusion may be increased every 30 minutes (Table 1). Do not exceed the infusion rates in Table 1.
Table 1. Infusion Rates for Arzerra in Previously Untreated CLL, Relapsed CLL, and Extended Treatment in CLL
Start of Infusion (min)
|Initial 300 mg Dosea |
|Subsequent Infusionsb |
|a Initial 300 mg: median durations of infusions = 4.8 to 5.2 hours.|
b Subsequent infusions of 1,000 mg: median durations of infusions = 4.2 to 4.4 hours.
- Infusion 1 (300-mg dose): Initiate infusion at a rate of 3.6 mg/hour (12 mL/hour).
- Infusion 2 (2,000-mg dose): Initiate infusion at a rate of 24 mg/hour (12 mL/hour).
- Infusions 3 through 12 (2,000-mg doses): Initiate infusion at a rate of 50 mg/hour (25 mL/hour).
In the absence of an infusion-related adverse event, the rate of infusion may be increased every 30 minutes (Table 2). Do not exceed the infusion rates in Table 2.
Table 2. Infusion Rates for Arzerra in Refractory CLL
|Interval after Start of Infusion (min)||Infusions 1 and 2a |
|Subsequent Infusions b |
|a Infusions 1 and 2 (300 mg and 2,000 mg): median duration of infusions = 6.8 hours.|
b Subsequent infusions of 2,000 mg: median durations of infusions = 4.2 to 4.4 hours.
Infusion Rate Dose Modification For Infusion Reactions
- Interrupt infusion for infusion reactions of any severity. Treatment can be resumed at the discretion of the treating physician. The following infusion rate modifications can be used as a guide.
- If the infusion reaction resolves or remains less than or equal to Grade 2, resume infusion with the following modifications according to the initial Grade of the infusion reaction.
- Grade 1 or 2: Infuse at one-half of the previous infusion rate.
- Grade 3 or 4: Infuse at a rate of 12 mL/hour.
- After resuming the infusion, the infusion rate may be increased according to Tables 1 and 2 above, based on patient tolerance.
- Consider permanent discontinuation of Arzerra if the severity of the infusion reaction does not resolve to less than or equal to Grade 2 despite adequate clinical intervention.
- Permanently discontinue therapy for patients who develop an anaphylactic reaction to Arzerra.
Patients should receive all of the following premedication agents 30 minutes to 2 hours prior to each infusion of Arzerra. See Table 3 for pre-medication schedule prior to each infusion.
Table 3. Premedication Schedule for Arzerra
|Previously Untreated CLL, Relapsed CLL or Extended Treatment in CLL||Refractory CLL|
|Infusion Number||1 and 2||3 and beyonda||1, 2, and 9||3 to 8||10 to 12|
|Intravenous corticosteroid (prednisolone or equivalent)||50 mg||0-50 mgb||100 mg||0-100 mgb||50-100 mgc|
|Oral acetaminophen||1,000 mg|
|Oral or intravenous antihistamine||Diphenhydramine 50 mg or cetirizine 10 mg (or quivalent)|
|a Up to 13 infusions in previously untreated CLL; up to 7 infusions in relapsed CLL, up to 14 infusions in extended treatment in CLL.|
b Corticosteroid may be reduced or omitted for subsequent infusions if a Grade 3 or greater infusion-related adverse event did not occur with the preceding infusion(s).
c Prednisolone may be given at reduced dose of 50 mg to 100 mg (or equivalent) if a Grade 3 or greater infusion-related adverse event did not occur with Infusion 9.
Preparation And Administration
- Do not shake product.
- Inspect parenteral drug products visually for particulate matter and discoloration prior to administration. Arzerra should be a clear to opalescent, colorless solution. The solution should not be used if discolored or cloudy, or if foreign particulate matter is present.
Preparation Of Solution:
- 300-mg dose: Withdraw and discard 15 mL from a 1,000-mL bag of 0.9% Sodium Chloride Injection, USP. Withdraw 5 mL from each of 3 single-use 100-mg vials of Arzerra and add to the bag. Mix diluted solution by gentle inversion.
- 1,000-mg dose: Withdraw and discard 50 mL from a 1,000-mL bag of 0.9% Sodium Chloride Injection, USP. Withdraw 50 mL from 1 single-use 1,000-mg vial of Arzerra and add to the bag. Mix diluted solution by gentle inversion.
- 2,000-mg dose: Withdraw and discard 100 mL from a 1,000-mL bag of 0.9% Sodium Chloride Injection, USP. Withdraw 50 mL from each of 2 single-use 1,000-mg vials of Arzerra and add to the bag. Mix diluted solution by gentle inversion.
- Store diluted solution between 2° to 8°C (36° to 46°F).
- No incompatibilities between Arzerra and polyvinylchloride or polyolefin bags and administration sets have been observed.
- Do not mix Arzerra with, or administer as an infusion with other medicinal products.
- Administer using an infusion pump and an administration set.
- Flush the intravenous line with 0.9% Sodium Chloride Injection, USP before and after each dose.
- Start infusion within 12 hours of preparation.
- Discard prepared solution after 24 hours.
Is Arzerra safe to use while pregnant or breastfeeding?
- Arzerra may cause fetal B-cell depletion based on findings from animal studies and the drug's mechanism of action.
- There are no data on Arzerra use in pregnant women to inform a drug-associated risk. However, there are clinical considerations.
- There is no information regarding the presence of Arzerra in human milk, the effects on the breastfed infant, or the effects on milk production.
- Human IgG is known to be present in human milk. Published data suggest that antibodies in breast milk do not enter the neonatal and infant circulations in substantial amounts.
Latest Cancer News
Daily Health News
Arzerra (ofatumumab) Injection is a monoclonal antibody used to treat chronic lymphocytic leukemia. Common side effects of Arzerra include nausea, vomiting, diarrhea, tiredness, swelling of hands/ankles/feet, trouble sleeping, skin rash, or cold symptoms such as stuffy nose, sneezing, and sore throat. Arzerra decreases bone marrow function, which can cause anemia.
Multimedia: Slideshows, Images & Quizzes
Understanding Cancer: Metastasis, Stages of Cancer, and More
Learn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read...
Signs of Cancer in Women: Symptoms You Can't Ignore
Colon and stomach cancer symptoms can surprise women but can be treated if detected early. Learn about breast cancer signs and...
Blood Cancer Types: Leukemia, Lymphomas, Myelomas, and More
Types of blood cancers include leukemia, lymphomas, multiple myelomas, and others discussed in this slideshow. Symptoms may...
Cancer-Fighting Foods: Resveratrol, Green Tea, and More
Experts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help...
Cancer: Guide to Leukemia
Learn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer...
Cancer: Symptoms of Common Cancers in Men
Can men get breast cancer? Cancer symptoms men need to watch out for include skin changes, difficulty swallowing, rapid weight...
Cancer: Visual Guide to Thyroid Cancer
Find out the symptoms of thyroid cancer, and learn how to treat it after you get a diagnosis.
Cancer: Does This Cause Cancer?
Everything gives you cancer, right? Not really. WebMD's slide show tells you about the research into cancer and cell phones,...
Leukemia Quiz: Test Your Medical IQ
What do you know about leukemia? Did you know there are different types? What are the symptoms? Take the Leukemia Quiz and test...
Top 10 Cancers Quiz
Take this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most...
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
Cancer: Cancer 'Remedies' That Don't Work
You may have read about an all-natural cure for cancer. While many therapies are helpful, some aren't worth your time or money....
Cancer: Guide to Testicular Cancer
Testicular cancer is one of the most common cancers for men ages 15 to 35, but it's very treatable. WebMD explains when to see...
Cancer Guide to Eye Cancers
Find out more from WebMD about the early signs of these types of cancer and how they’re diagnosed and treated.
Related Disease Conditions
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
Leukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly speaking, leukemia should refer only to cancer of the white blood cells (the leukocytes) but in practice it can apply to malignancy of any cellular element in the blood or bone marrow, as in red cell leukemia (erythroleukemia).
What Is the Life Expectancy of a Person With Leukemia?
Leukemia is a group of cancers of the blood affecting the white blood cells. White blood cells are the infection-fighting cells of the body. In adults, leukemia is most common in people older than 55 years, with the average age of diagnosis being 66 years. It is also one of the most common cancers in children and adults younger than 20 years. The survival rate is higher for younger people.
Cancer Risk Factors and Causes
Though it's difficult to say why some people develop cancer while others don't, research shows that certain risk factors increase a person's odds of developing cancer. These risk factors include growing older, family history of cancer, diet, alcohol and tobacco use, and exposure to sunlight, ionizing radiation, certain chemicals, and some viruses and bacteria.
How Does Leukemia Kill?
Leukemia is a cancer of the white blood cells of the bone marrow. Patients with leukemia have an over-production of a particular blood cell type in the body, the white blood cells (cells that fight infection, and provide immunity).
Second Source article from Government
What Type of Cancer Makes You Very Tired?
Extreme and recurrent tiredness is one of the common symptoms of most types of cancers. Tiredness is usually considered a warning sign of cancer progressing. Tiredness related to cancers usually does not get better with adequate rest or sleep.
Survival Rate for Acute Lymphoblastic Leukemia
The prognosis depends on the type of leukemia, the extent of the disease, age of the patient, and the general condition of the patient. Some patients can go into complete remission. The average five-year survival rate of leukemia is 60-65%.
Which Cancer Is the Most Painful?
Cancer spreading to the bone is the most painful type of cancer. Pain can be caused by a tumor pressing on the nerves around the bone. As the tumor size increases, it can release chemicals that irritate the area around the tumor.
At What Stage of Cancer is Chemotherapy Used?
The decision to use chemotherapy may vary depending on the aggressiveness, stage and type of cancer. Usually, chemotherapy may be used for all stages in most cancer types. Chemotherapy is a type of medicine or combination of medications that is used to treat or kill cancer cells.
Which Is the Deadliest Cancer?
Lung cancer is considered to be the most deadly cancer. More people die from lung cancer each year than from breast, colorectal and prostate cancer combined.
Cancer fatigue is a lack of energy that is caused by cancer or cancer treatment, including chemotherapy, radiation, biological therapy, or bone marrow transplantation. Strategies to combat cancer fatigue include scheduling rest, pacing oneself, planning ahead and prioritizing work and activities, eating the right foods, exercising, and practicing proper body mechanics.
What Is the BRCA Gene?
BRCA genes (BRCA 1 and 2, when normal, repair damaged DNA) are among the genetic mutations linked to breast cancer, ovarian cancer, and other cancers when mutated. Every woman with a BRCA mutation is at high risk for breast cancer, irrespective of whether she has a family history of breast cancer or not. By age 80, a woman with a BRCA mutation has about an 80% chance of developing breast cancer. BRCA1 and BRCA2 gene mutations also increase the risk of ovarian cancer, by 54% and 23%, respectively.
Certain behavioral, lifestyle, and environmental factors contribute to cancer. Cancer prevention involves modifying these factors to decrease cancer risk. Tobacco use, alcohol consumption, physical inactivity, inadequate fruit and vegetable intake, and obesity increase the risk of certain cancers. Vaccines, genetic testing, and cancer screening also play a role in cancer prevention.
What Are the Stages of Chronic Lymphocytic Leukemia?
Chronic lymphocytic leukemia is a cancer of the blood and bone marrow. With this type of cancer, the marrow creates too many abnormal lymphocytes. There are five stages of chronic lymphocytic leukemia.
Childhood Acute Lymphoblastic Leukemia (ALL)
Childhood acute lymphoblastic leukemia is the most common type of cancer in children. Symptoms and signs include fever, easy bruising, bone or joint pain, weakness, loss of appetite, and painless lumps in the neck, underarm, stomach, or groin. Treatment depends upon staging and may include chemotherapy, radiation, or stem cell transplant.
Cancer pain results from the tumor pressing on nerves or invading bones or organs. Cancer treatments like chemotherapy, radiation, or surgery can also cause pain. Over-the-counter pain relievers, prescription medications, radiation, biofeedback, and relaxation techniques are just some treatments for cancer pain.
Leukemia: Signs, Symptoms, And Complications
Leukemia results when the genetic material (DNA) of a single cell in the bone marrow transforms, this is called a mutation. A mutated cell does not perform body function, but it eats away the nutrition meant for the normal cells.
What Are the Top Ten Cancers?
Lung cancer is the number one killer cancer in the world. It is the most common cause of cancer-related deaths in both men and women.
How Can We Prevent Cancer?
Cancer is a medical condition in which cells grow out of control and crowd out the normal cells. This makes it difficult for the body to work the way it should. Cancer can start at any place in the body. There are many types of cancer. It’s not just one disease. Cancer can start in the lungs, breast, colon, or blood.
Treatment & Diagnosis
- Cancer: Confronting Cancer with Humor
- Cancer Survival and Attitude with Hamilton Jordan
- Cancer and Green Tea
- Cancer Treatment: Writing to Heal with Margie Davis
- Cancers: Children's Cancers
- Cancer: Living Well Despite with Win Boerckel
- Cancer: Childhood Cancer Survivors
- Cancer: Journaling to Save Your Life
- Cancer Pain Management with Ann Reiner
- Cancer: The Importance of Joining a Cancer Support Group with Selma Schimmel
- Cancer Patients Need Proper Diet and Exercise
- Cancer Research: Going the Distance
- Leukemia FAQs
- Cancer FAQs
- Evolution of Treatment for a Rare Type of Leukemia
- Gleevec and Chronic Myeloid Leukemia
- How Familes Cope with a Leukemia Diagnosis
- Coping with a Bad Disease - Community Counts
- A Family's Leukemia Diary - Coping
- Cancer Survivor?
- Cancer,Stroke & Heart Attack Risks- ReducedThrough Walking
- Cancer Care in the Elderly
- Is Multiple Myeloma the Same as Leukemia?
- Can Folic Acid Prevent Leukemia?
- Does Folic Acid Prevent Leukemia?
- What Is the Number One Cause of Cancer?
- Does Stress Cause Cancer?
- Complementary and Alternative Cancer Treatments
- 10 Cancer Symptoms That Men Ignore
- Chronic Myelogenous Leukemia (CML)
- Cancer Prevention: The Anticancer Diet
Medications & Supplements
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.